Tumor cell killing mechanisms of epidermal growth factor receptor (EGFR) antibodies are not affected by lung cancer-associated EGFR kinase mutations.

Peipp, M.; Schneider-Merck, T.; Dechant, M.; Beyer, T.; Lammerts van Bueren, J.J.; Bleeker, W.K.; Parren, P.W.H.I.; van de Winkel, J.G.J.; Valerius, T.

Tumor cell killing mechanisms of epidermal growth factor receptor (EGFR) antibodies are not affected by lung cancer-associated EGFR kinase mutations.

DSpace/Manakin Repository

Tumor cell killing mechanisms of epidermal growth factor receptor (EGFR) antibodies are not affected by lung cancer-associated EGFR kinase mutations.

Peipp, M.; Schneider-Merck, T.; Dechant, M.; Beyer, T.; Lammerts van Bueren, J.J.; Bleeker, W.K.; Parren, P.W.H.I.; van de Winkel, J.G.J.; Valerius, T.

(2008) Journal of Immunology, volume 180, issue 6, pp. 4338 - 4345

(Article)

Download/Full Text

Open Access version via Utrecht University Repository

Unknown

ISSN: 0022-1767

Publisher: American Association of Immunologists

(Peer reviewed)

See more statistics about this item